Background We conducted a scoping review focused on various forms of substance use
amid the pandemic, looking at both the impact of substance use on COVID-19 infection …

Adherence to and retention in Medication Treatment for Opioid Use Disorders (MOUD)
persist. We systematically reviewed trends of USA MOUD adherence, retention, and barriers …

Background Medications for opioid use disorder (MOUD; methadone, buprenorphine,
naltrexone) are the most effective treatments for OUD, and MOUD is protective against fatal …

Objective Retaining adolescents and young adults (AYA) in medications for opioid use
disorder (MOUD), like methadone maintenance treatment (MMT), is critical to reducing toxic …

Opioid use disorder (OUD) is a major public health emergency in the United States. In 2020,
2.7 million individuals had an OUD. Medication for opioid use disorder is the evidence …

Recovery capital (RC) encompasses the wide range of resources individuals can employ to
recover from Substance Use Disorder (SUD). It consists of five subdomains: human, social …

Background The decades-long opioid epidemic and the more recent COVID-19 pandemic
are two interacting events with significant public health impacts for people with opioid use …

The 2017 declaration of the opioid overdose epidemic as a public health emergency in the
United States enhanced a national focus on effective and sustainable treatments for opioid …

Objective: There are tens of millions of problem gamblers in the world, many of whom either
do not seek treatment or fail to commit to it. Dropout rates are high, and not enough is known …

Introduction Increasing evidence-based treatment for opioid use disorder (OUD) is key to
reducing opioid-related morbidity and mortality. Family and close friends of people with OUD …